Publication: 4565

Publication: 4565

A phase II (Alliance/A091802) randomized trial of avelumab plus cetuximab vs. avelumab alone in advanced cutaneous squamous cell carcinoma (cSCC)

DOI

Google Scholar

Citation:

Meeting Instance:: ASCO 2025
Year:: 2025
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 4643

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; U24CA196171; U10CA180868 (NRG Oncology); U10CA180888 (SWOG);

Corr. Author:
Authors:: Dan P. Zandberg Jake B. Allred Ari Joseph Rosenberg John M. Kaczmar PL Swiecicki Julian A. Ricklie Andrew Poklepovic Jessica R. Bauman Minh Phan Nabil F. Saba John A. Ellerton K Cordes Stephanie Berg Pamela N. Munster Gary K. Schwartz

Networks:: CA824, LAPS-IL057, LAPS-MA036, LAPS-MI014, LAPS-MN026, LAPS-OK003, LAPS-PA015, MUSC, NCRF, OH029, VCU

Study: Alliance-A091802
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: